4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018331
Chief Business Officer acquired 2,912 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ISACSON CHRISTINA K. Chief Business Officer | 2018-06-25 | Conversion | +2,912 | 103,531 | D | ||
| Derivatives | |||||||
| ISACSON CHRISTINA K. Chief Business Officer | 2018-06-25 | Conversion · Series A Preferred Stock | −6,670 | 0 | D | ||
| ISACSON CHRISTINA K. Chief Business Officer | 2018-06-25 | Conversion · Series B Preferred Stock | −857 | 0 | D | ||
Loading xslF345X03/doc4.xml…